Clinical Trial: Role of Glucagon-like Peptide-1 Receptor Agonists in Menstrual Irregularities in Adolescent Females With Type 1 Diabetes Mellitus

U.S., Jan. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07319286) titled 'Role of Glucagon-like Peptide-1 Receptor Agonists in Menstrual Irregularities in Adolescent Females With Type 1 Diabetes Mellitus' on Dec. 05, 2025.

Brief Summary: The aim of this study is to measure the frequency of menstrual irregularities among adolescent females with Type 1 diabetes mellitus and to assess the therapeutic effect of glucagon-like peptide-1 receptor agonist on menstrual irregularities in adolescent females with Type 1 diabetes mellitus .

Study Start Date: Aug. 04, 2025

Study Type: INTERVENTIONAL

Condition: Menstrual Irregularities Type1 Diabetes Mellitus

Intervention: DRUG: Dulaglutide

All studied patients wi...